A2A Pharmaceuticals, Inc.

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$805,500.13
Insider Sells Quantity
9
Insider Sells Sum
$26.55M

Insider Activity of A2A Pharmaceuticals, Inc.

The largest purchase of all time was on 2022-08-16 and amounted to 30684 shares of Biomea Fusion, Inc. for $425,648.

The largest sale of all time was on 2023-03-31 and amounted to 200000 shares of Biomea Fusion, Inc. for $6.25M.

Biography of A2A Pharmaceuticals, Inc.

No biography is available at this moment.

2023-06-01SaleBiomea Fusion, Inc.
BMEA
10 percent owner
50,000
0.1638%
$34.56$1.73M-57.4%
2023-05-31SaleBiomea Fusion, Inc.
BMEA
10 percent owner
75,000
0.2524%
$33.81$2.54M-55.18%
2023-05-12SaleBiomea Fusion, Inc.
BMEA
10 percent owner
25,000
0.0841%
$33.84$846,000-53.6%
2023-05-09SaleBiomea Fusion, Inc.
BMEA
10 percent owner
150,000
0.5185%
$34.50$5.18M-53.17%
2023-05-08SaleBiomea Fusion, Inc.
BMEA
10 percent owner
100,000
0.3445%
$33.99$3.4M-52.59%
2023-04-20SaleBiomea Fusion, Inc.
BMEA
10 percent owner
200,000
0.6723%
$29.12$5.82M-43.7%
2023-03-31SaleBiomea Fusion, Inc.
BMEA
10 percent owner
200,000
0.6812%
$31.25$6.25M-45.44%
2022-08-16PurchaseBiomea Fusion, Inc.
BMEA
30,684
0.1067%
$13.87$425,648-9.74%
2022-07-21SaleBiomea Fusion, Inc.
BMEA
34,658
0.1118%
$11.21$388,516-2.11%
2022-06-24SaleBiomea Fusion, Inc.
BMEA
34,658
0.1168%
$11.76$407,578-5.69%
2021-09-17PurchaseBiomea Fusion, Inc.
BMEA
10 percent owner
34,658
0.1193%
$10.96$379,852-20.13%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.